

Several times a year the Center for Drug Evaluation and Research sends out an update to share information on new developments, opportunities, and initiatives in regulatory science with the goal of advancing medical product development. 2025 Issue I, 2025 (PDF - 442 KB) Issue II, 2025 (PDF - 699 KB) 2024 Issue I, 2024 (PDF - 1 MB) Issue II, 2024 (PDF - 648 KB) Issue III, 2024 (PDF - 3 MB) 2023 Issue I, 2023 (PDF - 638 KB) Issue II, 2023 (PDF - 701 KB) Issue III, 2023 (PDF - 3 MB) 2022 Spring 2022 (PDF - 782 KB) Fall 2022 (PDF - 554 KB) Winter 2022 (PDF - 570 KB) 2021 Spring 2021 (PDF - 628 KB) Summer 2021 (PDF - 653 KB) Fall 2021 (PDF - 601 KB) 2020 Spring 2020 (PDF - 641 KB) Summer 2020 (PDF - 444 KB) Fall 2020 (PDF - 524 KB) Email Us If you have comments or questions, contact the CDER Office of Translational Sciences at OTSCommunications@fda.hhs.gov.
What's New: Drugs
|15th Jan, 2026
|FDA
What's New: Drugs
|15th Jan, 2026
|FDA
What's New: Drugs
|15th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA